ImPACt on Invasive Fungal Infections by Immune Checkpoint Inhibition

Anidulafungin in Patients With Hematologic Malignancies

NCT01053884 ·Status: TERMINATED ·Phase: PHASE2

The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis

NCT05235711 ·Status: COMPLETED

Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)

NCT00230243 ·Status: COMPLETED

Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)

NCT01490138 ·Status: UNKNOWN

Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections

NCT02492594 ·Status: COMPLETED

Evaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised Patients

NCT01902030 ·Status: UNKNOWN

Natural History of Individuals With Immune System Problems That Lead to Fungal Infections

NCT01386437 ·Status: RECRUITING

Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)

NCT00548080 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

NCT00002277 ·Status: COMPLETED ·Phase: PHASE3

Empirical Versus Preemptive Antifungal Therapy

NCT01288378 ·Status: COMPLETED ·Phase: PHASE3

Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy

NCT03221075 ·Status: COMPLETED

A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)

NCT01174147 ·Status: COMPLETED

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

NCT04738955 ·Status: UNKNOWN ·Phase: PHASE4

Identification of Serum and/or Plasma Biomarkers for the Diagnosis Prognosis and/or Prediction of Invasive Mycosis in Neutropenic Patients

NCT01907477 ·Status: COMPLETED ·Phase: NA

A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease

NCT06376201 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis

NCT00404092 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy

NCT01439646 ·Status: COMPLETED

Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)

NCT00083343 ·Status: COMPLETED ·Phase: PHASE2

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

NCT01576653 ·Status: COMPLETED ·Phase: NA

Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility

NCT01077336 ·Status: COMPLETED

Study of Micafungin in Patients With Invasive Candidiasis or Candidemia

NCT00105144 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

NCT01982071 ·Status: TERMINATED ·Phase: PHASE4

Micafungin Salvage Mono-therapy in Invasive Aspergillosis

NCT00376337 ·Status: TERMINATED ·Phase: PHASE2

Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI)

NCT07272915 ·Status: COMPLETED

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952 ·Status: COMPLETED